IMV INC (IMV) Fundamental Analysis & Valuation

NASDAQ:IMV • CA44974L3011

Current stock price

0.8225 USD
-0.02 (-2.55%)
At close:
0.8 USD
-0.02 (-2.74%)
After Hours:

This IMV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. IMV Profitability Analysis

1.1 Basic Checks

  • IMV had negative earnings in the past year.
  • IMV had a negative operating cash flow in the past year.
IMV Yearly Net Income VS EBIT VS OCF VS FCFIMV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M

1.2 Ratios

  • IMV has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IMV Yearly ROA, ROE, ROICIMV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 0 200 -200 400 -400

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for IMV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IMV Yearly Profit, Operating, Gross MarginsIMV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 -5K -10K -15K -20K

2

2. IMV Health Analysis

2.1 Basic Checks

  • IMV does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, IMV has more shares outstanding
  • Compared to 1 year ago, IMV has a worse debt to assets ratio.
IMV Yearly Shares OutstandingIMV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M
IMV Yearly Total Debt VS Total AssetsIMV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

2.2 Solvency

  • Based on the Altman-Z score of -12.68, we must say that IMV is in the distress zone and has some risk of bankruptcy.
  • IMV has a worse Altman-Z score (-12.68) than 82.15% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.68
ROIC/WACCN/A
WACC6.97%
IMV Yearly LT Debt VS Equity VS FCFIMV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M

2.3 Liquidity

  • IMV has a Current Ratio of 2.93. This indicates that IMV is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of IMV (2.93) is worse than 71.88% of its industry peers.
  • IMV has a Quick Ratio of 2.93. This indicates that IMV is financially healthy and has no problem in meeting its short term obligations.
  • IMV has a Quick ratio of 2.93. This is in the lower half of the industry: IMV underperforms 70.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.93
IMV Yearly Current Assets VS Current LiabilitesIMV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M

6

3. IMV Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 4.44% over the past year.
  • The Revenue has grown by 37.21% in the past year. This is a very strong growth!
  • IMV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.12% yearly.
EPS 1Y (TTM)4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
Revenue 1Y (TTM)37.21%
Revenue growth 3Y-8.54%
Revenue growth 5Y14.12%
Sales Q2Q%337.14%

3.2 Future

  • Based on estimates for the next years, IMV will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.36% on average per year.
  • Based on estimates for the next years, IMV will show a very strong growth in Revenue. The Revenue will grow by 162.00% on average per year.
EPS Next Y20.34%
EPS Next 2Y22.41%
EPS Next 3Y17.34%
EPS Next 5Y15.36%
Revenue Next Year-80.66%
Revenue Next 2Y59.28%
Revenue Next 3Y71.75%
Revenue Next 5Y162%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMV Yearly Revenue VS EstimatesIMV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
IMV Yearly EPS VS EstimatesIMV Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 -2 -4

0

4. IMV Valuation Analysis

4.1 Price/Earnings Ratio

  • IMV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IMV. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IMV Price Earnings VS Forward Price EarningsIMV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IMV Per share dataIMV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3 -4

4.3 Compensation for Growth

  • IMV's earnings are expected to grow with 17.34% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.41%
EPS Next 3Y17.34%

0

5. IMV Dividend Analysis

5.1 Amount

  • IMV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMV Fundamentals: All Metrics, Ratios and Statistics

IMV INC

NASDAQ:IMV (4/28/2023, 8:22:14 PM)

After market: 0.8 -0.02 (-2.74%)

0.8225

-0.02 (-2.55%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)03-16
Earnings (Next)05-11
Inst Owners0.01%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.63M
Revenue(TTM)354.00K
Net Income(TTM)-48.50M
Analysts80
Price Target21.8 (2550.46%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)21.77%
Min EPS beat(2)18.66%
Max EPS beat(2)24.89%
EPS beat(4)4
Avg EPS beat(4)17.9%
Min EPS beat(4)11.99%
Max EPS beat(4)24.89%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)362.62%
Min Revenue beat(2)302.87%
Max Revenue beat(2)422.36%
Revenue beat(4)3
Avg Revenue beat(4)202.15%
Min Revenue beat(4)-14.65%
Max Revenue beat(4)422.36%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)6.67%
PT rev (3m)-7.42%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.5%
EPS NY rev (1m)-12.6%
EPS NY rev (3m)-782.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-50%
Revenue NY rev (1m)-84.75%
Revenue NY rev (3m)-88.34%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 27.21
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.59
EYN/A
EPS(NY)-3.66
Fwd EYN/A
FCF(TTM)-2.94
FCFYN/A
OCF(TTM)-2.85
OCFYN/A
SpS0.03
BVpS-0.56
TBVpS-0.56
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 107.19%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 2.93
Altman-Z -12.68
F-Score2
WACC6.97%
ROIC/WACCN/A
Cap/Depr(3y)151.06%
Cap/Depr(5y)243.84%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)4.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%29.29%
EPS Next Y20.34%
EPS Next 2Y22.41%
EPS Next 3Y17.34%
EPS Next 5Y15.36%
Revenue 1Y (TTM)37.21%
Revenue growth 3Y-8.54%
Revenue growth 5Y14.12%
Sales Q2Q%337.14%
Revenue Next Year-80.66%
Revenue Next 2Y59.28%
Revenue Next 3Y71.75%
Revenue Next 5Y162%
EBIT growth 1Y-8.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-7.84%
EBIT Next 3Y-3.45%
EBIT Next 5Y16.26%
FCF growth 1Y-3.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.22%
OCF growth 3YN/A
OCF growth 5YN/A

IMV INC / IMV Fundamental Analysis FAQ

What is the ChartMill fundamental rating of IMV INC (IMV) stock?

ChartMill assigns a fundamental rating of 2 / 10 to IMV.


What is the valuation status of IMV INC (IMV) stock?

ChartMill assigns a valuation rating of 0 / 10 to IMV INC (IMV). This can be considered as Overvalued.


Can you provide the profitability details for IMV INC?

IMV INC (IMV) has a profitability rating of 0 / 10.


Can you provide the financial health for IMV stock?

The financial health rating of IMV INC (IMV) is 2 / 10.


Can you provide the expected EPS growth for IMV stock?

The Earnings per Share (EPS) of IMV INC (IMV) is expected to grow by 20.34% in the next year.